Strip Test Enables Home Monitoring of Heart Condition
By LabMedica International staff writers Posted on 05 Jun 2017 |
Image: A paper-based test strip could help people with heart failure know if their condition is worsening (Photo courtesy of the American Chemical Society).
Heart failure can often be managed with medications and lifestyle changes, but its progression needs to be monitored closely to adjust treatment and prevent emergency room visits. Now scientists have developed a simple paper test strip that could potentially allow patients to monitor themselves for the first time.
Antigens ST2 and BNP are good indicators of heart failure and its progression. Currently, analyzing the levels of these biomarkers requires trained personnel and sophisticated lab equipment. The research team, lead by study corresponding authors Prof. Feng Xu and Prof. Min Lin of Xi’an Jiaotong University (Xi’an, Shaanxi, China), devised a simple assay to enable doctors and patients to carry out the same analysis at the office or at home.
The team developed a fluorescent lateral-flow strip platform that requires a blood sample of only 10 microliters. A blue dot glows on the strip if ST2 is present in the sample, and a green dot glows if it contains BNP. The colors’ intensities increase with concentration, which indicates that a person’s heart failure is likely becoming worse. A smartphone app can analyze the readout and send the results to the patient’s doctor, who can adjust treatment accordingly.
Testing 38 serum samples from people with heart failure showed that the paper-based test closely matched conventional techniques.
The study, by You M et al, was published May 8, 2017, in the journal ACS Nano.
Related Links
Xi’an Jiaotong University
Antigens ST2 and BNP are good indicators of heart failure and its progression. Currently, analyzing the levels of these biomarkers requires trained personnel and sophisticated lab equipment. The research team, lead by study corresponding authors Prof. Feng Xu and Prof. Min Lin of Xi’an Jiaotong University (Xi’an, Shaanxi, China), devised a simple assay to enable doctors and patients to carry out the same analysis at the office or at home.
The team developed a fluorescent lateral-flow strip platform that requires a blood sample of only 10 microliters. A blue dot glows on the strip if ST2 is present in the sample, and a green dot glows if it contains BNP. The colors’ intensities increase with concentration, which indicates that a person’s heart failure is likely becoming worse. A smartphone app can analyze the readout and send the results to the patient’s doctor, who can adjust treatment accordingly.
Testing 38 serum samples from people with heart failure showed that the paper-based test closely matched conventional techniques.
The study, by You M et al, was published May 8, 2017, in the journal ACS Nano.
Related Links
Xi’an Jiaotong University
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms